2,065
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Cannabis use among pregnant women under different legalization frameworks in the United States

ORCID Icon, , , &
Pages 695-700 | Received 17 Feb 2022, Accepted 11 Oct 2022, Published online: 28 Nov 2022
 

ABSTRACT

Background: Cannabis use in pregnancy is associated with adverse neonatal outcomes, yet its use among pregnant women in the United States has increased significantly.

Objectives: This cross-sectional study explored how cannabis use in pregnant women varied between different cannabis legalization frameworks, that is, permitted use of cannabidiol (CBD)-only, medical cannabis, and adult-use cannabis.

Methods: Behavioral Risk Factor Surveillance System data from 2017 to 2020 was utilized with respondents classified by their state’s policies into CBD-only, medical, and adult-use groups. Outcome measures included prevalence of use and usage characteristics (frequency, method of intake, and reason for use) among pregnant women. Logistic regression models were estimated to evaluate the association between legal status and prevalence of use.

Results: The unweighted dataset included 1,992 pregnant women. Recent cannabis use was reported by (weighted proportions): 2.4% (95%CI: 0–4.4) of respondents in the CBD-only group, 7.1% (95%CI: 4.0–10.1) in the medical group and 6.9% (95%CI: 3.0–10.9) in the adult-use group. Compared to the CBD-only group, respondents in the medical and adult-use groups were 4.5-fold (adjusted; 95%CI: 1.4–14.7; p = .01) and 4.7-fold (adjusted; 95%CI: 1.3–16.2; p = .02) more likely to use cannabis. Across all groups, smoking was the most common method of intake and over 49% of users reported using partially or entirely for adult-use purposes.

Conclusions: The increased use with legalization motivates further research on the impacts of cannabis as a therapeutic agent during pregnancy and supports the need for increased screening and patient counseling regarding the potential effects of cannabis use on fetal development.

Disclosure statement

Hance Clarke and Karim S. Ladha are co-principal investigators of an observational study on medical cannabis funded by Shoppers Drug Mart.

Additional information

Funding

Ms. Vachhani was supported by Kennan Research Summer Student Program Research Award from St. Michael’s Hospital (Toronto, Canada). Dr. Wijeysundera, Dr. Clarke, and Dr. Ladha are supported in part by a Merit Award from the Department of Anesthesiology and Pain Medicine at the University of Toronto.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 987.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.